Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.

Slides:



Advertisements
Similar presentations
Advanced breast cancer
Advertisements

Cornelis J.H. van de Velde, MD, PhD,FRCPS(hon)FACS(hon) Professor of Surgery President ECCO - the European Cancer Organization Past-President European.
North Tees University Hospital Audit of T1 Rectal Cancers September 2013 – August 2014 Nicola Maguire Teaching fellow General Surgery 12/09/2014.
Polyps – Where do they come from and what do you do with them?!
State-of-the-art in the Surgical Treatment of Gastric Cancer in Shanghai Department of Surgery Rui Jin Hospital School of Medicine, SJTU.
Prof. Faisal Ghani Siddiqui FCPS; PGDip-bioethics; MCPS-HPE
Cancer of Unknown Primary Dr Chris Jones Consultant Medical Oncologist North of England Cancer Network Annual Conference 20 September 2013.
National Oesophago–Gastric Cancer Audit Comparing local and national figures.
Routine contrast radiology after oesophagectomy and total gastrectomy Mr A Madhavan Ms H Wescott Mr N Jennings Mr PA Davis Mr SMD Dresner MR YKS Vishwanath.
Oesophageal Cancer. -improving outcomes. Anil Kaul Consultant General and Upper GI Surgery St Helens and Knowsley Teaching Hospitals NHS Trust.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
Characteristics of submucosal gastric carcinoma with lymph node metastatic disease H J Son, S Y Song,1 S Kim,3 J H Noh,2 T S Sohn,2 D S Kim1 & J C Rhee.
Management of GIST Dr Kwan Ming Wa Tuen Mun Hospital.
Dr. LF Hung Department of Surgery, Tuen Mun Hospital, HKSAR
Reporting and Management of Early stage Colorectal Cancer Frank Carey Dundee.
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
West Midlands Cancer Intelligence Unit NHSBSP Surgical QA Data for the Year of Screening 1 April 2002 to 31 March 2003 Dr Gill Lawrence and Professor Jan.
The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.
The role of surgery in the management of mesothelioma Mr Martyn Carr Consultant Thoracic Surgeon Liverpool Heart and Chest Hospital.
Audit of EGFR mutation testing in patients with proven Non-Small Cell Lung Cancer On behalf of the North of England Cancer Network Lung NSSG Dr Naomi Chamberlin,
GASTRIC LYMPHOMAS Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.
Colorectal carcinoma Dr.Mohammadzadeh.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
Practice of Endoscopic Mucosal Resection: A Survey to Endoscopic Units in Europe Class 15 – FMUP – 2008/ th December 2008 André Carvalho, Ana Morais,
Gastric Cancer Gidon Almogy MD Department of General Surgery Hadassah University Hospital.
Northern Oesophago-Gastric Cancer Unit MDT meeting NECN Audit day 2012 Helen Jaretzke, Angie Tate, Jon Shenfine, Paula Brookes, Leigh-Anne Phillips, Gillian.
Accuracy of EUS in diagnosis of rectal cancer KKUH experience
Endoscopy Matters NICE guidance dyspepsia, New build, National Context & NAEDI Dr Michelle Gallagher Consultant Gastroenterologist.
Supporting people with active and advanced disease Need better data collection Discussion at MDT – new diagnosis support Identify best practice Early palliative.
The role of Endoscopy in Gastric Cancer Fergal Donnellan Gastroenterologist VGH.
LUCADA Jacqueline Brown Cancer Services Manager North Tees & Hartlepool Trust.
Cancer Information Framework Initial feedback on NWCN LUCADA submission 2006 data Wednesday 20 th February, 2008 Linda Roberts, Cancer Information Specialist,
Network Audit Patients with Confirmed Small Cell Lung Cancer Who Did Not Receive Chemotherapy Dr D N Leitch On Behalf of Lung Cancer NSSG NECN.
National Oesophago–Gastric Cancer Audit  This slide set is designed to ◦Summarise the main audit findings for presentation at local MDT meetings.
Northern Region Colorectal Liver Metastases Study Guru Raghavendra.
Endoluminal Treatment of Barrett’s and Early Cancer Brant K. Oelschlager, MD University of Washington.
Two-week wait referrals for malignant melanoma: A clinical audit carried out across four UK Cancer Networks South West Cancer Intelligence Service
R3 정명화 /Prof. 장재영 Gastrointest. Endosc. 2012; 75:39-46.
Association of Family History with Cancer Recurrence and Survival in Patients with Gastric Cancer Journal of Clinical Oncology : R2 Hwang.
TRIAL PARTICIPATION IN THE OVER 60s: A RE-AUDIT OF THE MANAGEMENT OF AML IN THE SOUTH WEST OF ENGLAND South West Cancer Intelligence Service
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
1 Motohiko Kato, Tsutomu Nishida, Katsumi Yamamoto, Shiro Hayashi, Shinji Kitamura, Takamasa,Yabuta, Toshiyuki Yoshio, Takeshi Nakamura, Masato Komori,6.
NORTHUMBRIA PANCREATIC CARCINOMAS – Jan 2013 – Jan 2014 Number of new pancreatic carcinoma referrals56 Number of case discussed in local MDT55 Number of.
RECTAL CARCINOMA AND PREOPERATIVE MRI: USING A NATIONAL DATASET FOR REGIONAL AUDIT South West Cancer Intelligence Service J Weeks
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
Long-term outcomes of combination of endoscopic submucosal dissection and laparoscopic lymph node dissection without gastrectomy for early gastric cancer.
Long-term outcomes of endoscopic submucosal dissection (ESD) for superficial esophageal squamous cell neoplasms Satoshi Ono, MD, Mitsuhiro Fujishiro, MD,
Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett’s Esophagus Ganapathy A. Prasad, M.D. Navtej S. Buttar,
Indications for gastrectomy after incomplete EMR for early gastric cancer Hideki Nagano1,4, Shigekazu Ohyama1, Tetsu Fukunaga1, Yasuyuki Seto1, Junko Fujisaki2,
Oesophago–Gastric Cancer Audit
Oesophago–Gastric Cancer
National Oesophago–Gastric Cancer Audit 2015.
1 Maidstone and Tunbridge Wells NHS Trust (Kent Oncology Centre)
The effect of neo-adjuvant chemotherapy on the discrepancy between the endoscopic ultrasonography (EUS) and pathological staging of oesophageal cancer.
Jane E Scullion Respiratory Nurse Consultant
Oesophago–Gastric Cancer
Oesophago–Gastric Cancer Audit
Dr James Carlton, Medical Adviser
M.Boal; J. Batt; P. Wilkerson; D.R. Titcomb
Oesophago–Gastric Cancer
Pathway for patients with suspected Upper GI (OG) Cancer
Hannah Marder Cancer Manager UH Bristol
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
Comparison of Surgical Therapy of Gastric Cancer in Japan and Germany
The STAR-TREC Trial SIV Presentation
National Oesophago-Gastric Cancer Audit
ESD and beyond – The benefits of “getting it early”
Presentation transcript:

Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer in the County Durham and Tees Valley Region – an audit of clinical practice

Introduction Oesophago-gastric cancer:  5 th most common malignancy and 4 th most common cause of cancer related deaths in the UK. Incidence increasing in many Western countries (13,500 people diagnosed in 2011,Cancer Research UK). 28 Cancer Networks in England and 2 in Wales. Prognosis:  Poor  1-year survival rates approx 30%  5-year survival rate 13%

What is early gastric cancer (EGC)?  Cancer which is limited to the mucosa and of the submucosa. Treatment of EGC using endoscopy pioneered in Japan, by endoscopic mucosal resection (>10,000 cases detected each year). corresponds to approximately 50% of all gastric cancers. Significantly less numbers in the West compared to the East (Japan, China, Korea). Technological advancements in endoscopic imaging and treatment methods in the East:  New endoscopic imaging techniques more widely used.  Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) well established. Early Gastric Cancer – a comparison between the East and West

National Esophagogastric Cancer Audit 2012 Specialist MDT discussions Including involvement of palliative Care 2 pathologists to assess and diagnose High Grade Dysplasia Cancer Network to have access to endoscopic therapies Careful assessment of patients for palliative chemotherapy (older age and low performance status)

Endoscopic Mucosal Resection First case report of EMR published in A treatment option for early-stage gastric carcinoma.  used diagnostically and therapeutically in both upper and lower GI tracts  significantly lower mortality and morbidity than surgery. Surgical gastrectomy was the only method of treatment for EGC before development of endoscopic mucosal resection (EMR) or endoscopic mucosectomy. Research shows :  many early gastric cancer patients did not have any metastatic lesions.  gastrectomy for resection of regional lymph nodes is not always required.  Less invasive than surgical gastrectomy without sacrificing possibility of a cure in early lesions.

Endoscopic Mucosal Resection Involves local excision of lesions confined to the mucosa.  may even have a role in the treatment of submucosal lesions in the GI tract.

Aims of this Audit Proportion of patients with Gastric Cancer who were at T1/T2 stage at time of diagnosis. Main methods of referral. Modality of treatment offered. Histology at first endoscopy and post- op. Number of cases treated by EMR. Is EMR something that should be more widely practiced?

Methods Patients with gastric cancer identified from the James Cook University Hospital Central Upper GI Cancer MDT database. Period of Audit: January 2011 – January hospitals: County Durham and Darlington Foundation Trust North Tees Hospital Hartlepool Hospital James Cook University Hospital. Out of 105 patients 12 were diagnosed to have early gastric cancer based on:  patients presenting with High Grade Dysplasia to T1/T2-NO-MO staging. A 13 point proforma was created to collect data on:  clinical presentationsmoking  Alcoholfamily history  route of referral endoscopy findings,  pre and post interventional histologyother investigations,  final MDT decision survival in months.

Results 12 of 105 gastric cancers were EGC (11.4%). mean age 74.8yrs (range 62-83yrs). M:F=9:3. On CT staging, all lesions were T1/T2, N0, M0 lesions. Endoscopic resection was carried out in only 1 patient, and all others had surgery.

Results

Symptoms at Presentation

Initial Endoscopy Findings

Pre-Op Endoscopic Histology

Endoscopic Mucosal Resection (EMR) ChromoendoscopyMarkingResecting Post resection 12 mth follow up Standard endoscopic view

Conclusions/Recommendations Approximately 10% of gastric cancers are early gastric cancers in our region. Endoscopic treatment is not frequently carried out, as in eastern countries. There may be an opportunity to increase endoscopic resections for these lesions.